These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34525925)

  • 1. Recent Developments in Oxazole Derivatives as Anticancer Agents: Review on Synthetic Strategies, Mechanism of Action and SAR Studies.
    Kulkarni S; Kaur K; Jaitak V
    Anticancer Agents Med Chem; 2022; 22(10):1859-1882. PubMed ID: 34525925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrazoles as anticancer agents: A review on synthetic strategies, mechanism of action and SAR studies.
    Dhiman N; Kaur K; Jaitak V
    Bioorg Med Chem; 2020 Aug; 28(15):115599. PubMed ID: 32631569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiazole and Related Heterocyclic Systems as Anticancer Agents: A Review on Synthetic Strategies, Mechanisms of Action and SAR Studies.
    Sahil ; Kaur K; Jaitak V
    Curr Med Chem; 2022 Aug; 29(29):4958-5009. PubMed ID: 35306982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Scenario of 1,3-oxazole Derivatives for Anticancer Activity.
    Yan X; Wen J; Zhou L; Fan L; Wang X; Xu Z
    Curr Top Med Chem; 2020; 20(21):1916-1937. PubMed ID: 32579505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of oxazole scaffold: a patent review (2006-2017).
    Kaur R; Palta K; Kumar M; Bhargava M; Dahiya L
    Expert Opin Ther Pat; 2018 Nov; 28(11):783-812. PubMed ID: 30239247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxazole-Based Compounds As Anticancer Agents.
    Chiacchio MA; Lanza G; Chiacchio U; Giofrè SV; Romeo R; Iannazzo D; Legnani L
    Curr Med Chem; 2019; 26(41):7337-7371. PubMed ID: 30501590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advance in oxazole-based medicinal chemistry.
    Zhang HZ; Zhao ZL; Zhou CH
    Eur J Med Chem; 2018 Jan; 144():444-492. PubMed ID: 29288945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Medicinal Chemist's Perspective Towards Structure Activity Relationship of Heterocycle Based Anticancer Agents.
    Nehra B; Mathew B; Chawla PA
    Curr Top Med Chem; 2022; 22(6):493-528. PubMed ID: 35021975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxazole-Bridged Combretastatin A-4 Derivatives with Tethered Hydroxamic Acids: Structure⁻Activity Relations of New Inhibitors of HDAC and/or Tubulin Function.
    Schmitt F; Gosch LC; Dittmer A; Rothemund M; Mueller T; Schobert R; Biersack B; Volkamer A; Höpfner M
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoxazole derivatives as anticancer agent: A review on synthetic strategies, mechanism of action and SAR studies.
    Arya GC; Kaur K; Jaitak V
    Eur J Med Chem; 2021 Oct; 221():113511. PubMed ID: 34000484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chalcone Scaffolds as Anticancer Drugs: A Review on Molecular Insight in Action of Mechanisms and Anticancer Properties.
    Shukla S; Sood AK; Goyal K; Singh A; Sharma V; Guliya N; Gulati S; Kumar S
    Anticancer Agents Med Chem; 2021; 21(13):1650-1670. PubMed ID: 33238850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of novel diaryl oxazole-based compounds as potential agents to treat pancreatic cancer.
    Shaw AY; Henderson MC; Flynn G; Samulitis B; Han H; Stratton SP; Chow HH; Hurley LH; Dorr RT
    J Pharmacol Exp Ther; 2009 Nov; 331(2):636-47. PubMed ID: 19657049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,3-Oxazole derivatives as potential anticancer agents: Computer modeling and experimental study.
    Semenyuta I; Kovalishyn V; Tanchuk V; Pilyo S; Zyabrev V; Blagodatnyy V; Trokhimenko O; Brovarets V; Metelytsia L
    Comput Biol Chem; 2016 Dec; 65():8-15. PubMed ID: 27684433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bestowal of Quinazoline Scaffold in Anticancer Drug Discovery.
    Das R; Mehta DK; Dhanawat M
    Anticancer Agents Med Chem; 2021; 21(11):1350-1368. PubMed ID: 32593282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of 2,3-dihydroimidazo[2,1-
    Shahin AI; Zaraei SO; Alzuraiqi S; Abdulateef Z; Abbas NE; Al-Tel TH; El-Gamal MI
    Future Med Chem; 2023 Oct; 15(20):1885-1901. PubMed ID: 37814826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ring fusion strategy for the synthesis of anthra[2,3-d]oxazole-2-thione-5,10-dione homologues as DNA topoisomerase inhibitors and as antitumor agents.
    Chen CL; Liu FL; Lee CC; Chen TC; Chang WW; Guh JH; Ahmed Ali AA; Chang DM; Huang HS
    Eur J Med Chem; 2014 Nov; 87():30-8. PubMed ID: 25240093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
    Yang M; Liu H; Zhang Y; Wang X; Xu Z
    Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxazole: A Promising Building Block for the Development of Potent Antitumor Agents.
    Zhou H; Cheng JQ; Wang ZS; Chen FH; Liu XH
    Curr Top Med Chem; 2016; 16(30):3582-3589. PubMed ID: 27086791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in the Synthesis of Oxazole-Based Molecules via van Leusen Oxazole Synthesis.
    Zheng X; Liu W; Zhang D
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32244317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Developments of Target Based Coumarin Derivatives as Potential Anticancer Agents.
    Goud NS; Kumar P; Bharath RD
    Mini Rev Med Chem; 2020; 20(17):1754-1766. PubMed ID: 32386492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.